Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab

Gil Awada, Bart Neyns, Yanina Jansen et al.|Annals of Oncology|2018

Cited by 4